TWI594765B - 口服調製劑 - Google Patents

口服調製劑 Download PDF

Info

Publication number
TWI594765B
TWI594765B TW102115265A TW102115265A TWI594765B TW I594765 B TWI594765 B TW I594765B TW 102115265 A TW102115265 A TW 102115265A TW 102115265 A TW102115265 A TW 102115265A TW I594765 B TWI594765 B TW I594765B
Authority
TW
Taiwan
Prior art keywords
weight
oral preparation
oral
present
drug
Prior art date
Application number
TW102115265A
Other languages
English (en)
Chinese (zh)
Other versions
TW201347773A (zh
Inventor
岩本太郎
倉橋伸幸
岡慶一
武田知加子
Original Assignee
大塚製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大塚製藥股份有限公司 filed Critical 大塚製藥股份有限公司
Publication of TW201347773A publication Critical patent/TW201347773A/zh
Application granted granted Critical
Publication of TWI594765B publication Critical patent/TWI594765B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
TW102115265A 2012-04-30 2013-04-29 口服調製劑 TWI594765B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261640474P 2012-04-30 2012-04-30
US201361783163P 2013-03-14 2013-03-14

Publications (2)

Publication Number Publication Date
TW201347773A TW201347773A (zh) 2013-12-01
TWI594765B true TWI594765B (zh) 2017-08-11

Family

ID=48483123

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102115265A TWI594765B (zh) 2012-04-30 2013-04-29 口服調製劑

Country Status (21)

Country Link
US (3) US20150126521A1 (cg-RX-API-DMAC7.html)
EP (1) EP2844232A1 (cg-RX-API-DMAC7.html)
JP (1) JP6360795B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150003898A (cg-RX-API-DMAC7.html)
CN (1) CN104271120A (cg-RX-API-DMAC7.html)
AR (1) AR091349A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013255256B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014026879A2 (cg-RX-API-DMAC7.html)
CA (1) CA2872004A1 (cg-RX-API-DMAC7.html)
CO (1) CO7151505A2 (cg-RX-API-DMAC7.html)
EA (1) EA026187B1 (cg-RX-API-DMAC7.html)
HK (1) HK1207290A1 (cg-RX-API-DMAC7.html)
IL (1) IL235111A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN09091A (cg-RX-API-DMAC7.html)
MX (1) MX2014013155A (cg-RX-API-DMAC7.html)
NZ (1) NZ630029A (cg-RX-API-DMAC7.html)
PH (1) PH12014502323A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201406261QA (cg-RX-API-DMAC7.html)
TW (1) TWI594765B (cg-RX-API-DMAC7.html)
WO (1) WO2013165021A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201408114B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109498556A (zh) * 2017-09-15 2019-03-22 万特制药(海南)有限公司 阿立哌唑口服溶液及其制备方法
WO2022176017A1 (ja) * 2021-02-16 2022-08-25 大塚製薬株式会社 非晶質体及び当該非晶質体を含む組成物
US11654108B1 (en) 2022-05-02 2023-05-23 Medicated Chews, Llc Sennoside medicated chews

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010116385A2 (en) * 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
WO2012046066A1 (en) * 2010-10-06 2012-04-12 Probio Asa Sour gelled emulsions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6517886B1 (en) * 1997-06-24 2003-02-11 Biovail Corporation International Positive hydration method of preparing confectionery and the resulting product
AUPQ970300A0 (en) * 2000-08-29 2000-09-21 Massa Nominees Pty Ltd Advanced wireless network
FR2822644B1 (fr) * 2001-03-30 2005-03-11 Roquette Freres Confiserie sans sucre
JP2004099558A (ja) * 2002-09-11 2004-04-02 Medorekkusu:Kk 医薬用ゼリー組成物
JP4547994B2 (ja) * 2004-06-02 2010-09-22 救急薬品工業株式会社 塊状物質含有積層フィルム状の可食性口腔内投与剤の製造方法および塊状物質含有積層フィルム状の可食性口腔内投与剤
JP4315393B2 (ja) 2005-04-14 2009-08-19 大塚製薬株式会社 複素環化合物
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
GB0818472D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110139164A1 (en) * 2009-12-15 2011-06-16 R. J. Reynolds Tobacco Company Tobacco Product And Method For Manufacture
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
JP5611672B2 (ja) * 2010-05-28 2014-10-22 ゼリア新薬工業株式会社 経口ゼリー剤
AR082494A1 (es) * 2010-08-24 2012-12-12 Otsuka Pharma Co Ltd Composicion en torta y en suspension con contenido de derivado de carbostirilo y derivado de aceite de silicona y/o aceite de silicona
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010116385A2 (en) * 2009-04-08 2010-10-14 Rubicon Research Private Limited Pharmaceutical compositions for alleviating unpleasant taste
WO2012046066A1 (en) * 2010-10-06 2012-04-12 Probio Asa Sour gelled emulsions

Also Published As

Publication number Publication date
IL235111A0 (en) 2014-12-31
IN2014DN09091A (cg-RX-API-DMAC7.html) 2015-05-22
CO7151505A2 (es) 2014-12-29
ZA201408114B (en) 2016-08-31
CA2872004A1 (en) 2013-11-07
PH12014502323A1 (en) 2015-01-12
JP2015515959A (ja) 2015-06-04
EP2844232A1 (en) 2015-03-11
AR091349A1 (es) 2015-01-28
HK1207290A1 (en) 2016-01-29
WO2013165021A1 (en) 2013-11-07
MX2014013155A (es) 2015-05-08
NZ630029A (en) 2016-05-27
SG10201608954UA (en) 2016-12-29
EA026187B1 (ru) 2017-03-31
TW201347773A (zh) 2013-12-01
SG11201406261QA (en) 2014-11-27
US20150126521A1 (en) 2015-05-07
JP6360795B2 (ja) 2018-07-18
KR20150003898A (ko) 2015-01-09
AU2013255256A2 (en) 2014-11-13
AU2013255256A1 (en) 2014-10-30
US20170202833A1 (en) 2017-07-20
CN104271120A (zh) 2015-01-07
EA201491995A1 (ru) 2015-02-27
US20180055840A1 (en) 2018-03-01
AU2013255256B2 (en) 2017-09-07
BR112014026879A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
JP5674666B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
JP6294479B2 (ja) 経口分散性フィルム
JP5674667B2 (ja) 崩壊性粒子組成物及び口腔内速崩壊錠
JP5215172B2 (ja) 乾式直打速崩壊性錠剤
KR20090113777A (ko) 불쾌한 맛을 은폐한 경구 조성물
JP2015078182A (ja) 速崩壊性圧縮成型物及びその製法
CN114901264A (zh) 药物制剂
TWI594765B (zh) 口服調製劑
WO2006070845A1 (ja) 速崩壊性錠剤及びその製造方法
JP2006028028A (ja) 経口医薬組成物
US11135217B2 (en) Manufacturing process of formulation having improved content uniformity
TW201212953A (en) Coating agent for solid pharmaceutical preparation, film coating preparation for pharmaceutical use and coated solid pharmaceutical preparation
ES2450944T3 (es) Composición y comprimido que comprenden raltegravir
UA113646C2 (xx) Пероральний препарат
JP2020083884A (ja) イブプロフェン含有経口用医薬製剤
JP2012188383A (ja) ドネペジル塩酸塩の内用液剤
JP2011201876A (ja) 固形医薬組成物及び医薬製剤
JP2005179311A (ja) ゼリー状睡眠薬製剤
JP5817715B2 (ja) 固形医薬組成物、医薬製剤及び固形医薬組成物の製造方法
JP2012184171A (ja) 固形医薬組成物及び医薬製剤
JP2013035777A (ja) 固形医薬組成物及び医薬製剤
JP2010095490A (ja) 錠剤の製造方法

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees